SEC Form 4 · accession 0001609351-17-000046
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Milano
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $50.93 | May 31, 2017 | A | 4,000 | A | — | May 30, 2027 | Common Stock | 4,000 | 4,000 | D |
| Restricted Stock UnitsF2,F3 | — | May 31, 2017 | A | 1,500 | A | — | — | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1100% of the shares vest on the one-year anniversary of the grant date.
- F2Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics Inc. common stock.
- F3100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date.